Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 4Adenocarcinoma of Lung 2Solitary Pulmonary Nodule 1Respiratory Aspiration 1NSCLC 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Radiotherapy 4Pemetrexed 4Carboplatin 4pembrolizumab 3osimertinib 3aflutinib 3Radiosurgery 3Drug Therapy 3toripalimab 2Docetaxel 2tislelizumab 1sugemalimab 1lenvatinib 1cemiplimab 1brigatinib 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Surgical Procedures, Operative 1S 1 (combination) 1Platinum Compounds 1Platinum 1Pharmaceutical Preparations 1Paclitaxel 1Neoadjuvant Therapy 1JDQ443 1Immune Checkpoint Inhibitors 1HM781-36B 1Gemcitabine 1Diphenhydramine 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NSCLC × Anterior Temporal Lobectomy × 1 year × Clear all
NCT07612722 2026-05-29

Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo

Guangdong Provincial People's Hospital

Phase NA Recruiting
585 enrolled
Thoracic

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡